Your browser doesn't support javascript.
Risk of Severe Coronavirus Disease 2019 Disease in Individuals With Down Syndrome: A Matched Cohort Study From a Large, Integrated Health Care System.
Ku, Jennifer H; Levin, Myron J; Luo, Yi; Florea, Ana; Lin, I Chun; Tian, Yun; Tseng, Hung Fu.
  • Ku JH; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
  • Levin MJ; Departments of Pediatrics and Medicine, School of Medicine, University of Colorado, Aurora, Colorado, USA.
  • Luo Y; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
  • Florea A; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
  • Lin IC; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
  • Tian Y; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
  • Tseng HF; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
J Infect Dis ; 226(5): 757-765, 2022 09 13.
Article in English | MEDLINE | ID: covidwho-2029040
ABSTRACT

BACKGROUND:

Down syndrome (DS) is associated with an increased risk of infections attributed to immune defects. Whether individuals with DS are at an increased risk of severe coronavirus disease 2019 (COVID-19) remains unclear.

METHODS:

In a matched cohort study, we evaluated the risk of COVID-19 infection and severe COVID-19 disease in individuals with DS and their matched counterparts in a pre-COVID-19 vaccination period at Kaiser Permanente Southern California. Multivariable Cox proportion hazard regression was used to investigate associations between DS and risk of COVID-19 infection and severe COVID-19 disease.

RESULTS:

Our cohort included 2541 individuals with DS and 10 164 without DS matched on age, sex, and race/ethnicity (51.6% female, 53.3% Hispanic, median age 25 years [interquartile range, 14-38]). Although the rate of COVID-19 infection in individuals with DS was 32% lower than their matched counterparts (adjusted hazard ratio [aHR], 0.68; 95% confidence interval [CI], .56-.83), the rate of severe COVID-19 disease was 6-fold higher (aHR, 6.14; 95% CI, 1.87-20.16).

CONCLUSIONS:

Although the risk of COVID-19 infection is lower, the risk of severe disease is higher in individuals with DS compared with their matched counterparts. Better infection monitoring, early treatment, and promotion of vaccine for COVID-19 are warranted for DS populations.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Down Syndrome / Delivery of Health Care, Integrated / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Adult / Female / Humans / Male Language: English Journal: J Infect Dis Year: 2022 Document Type: Article Affiliation country: Infdis

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Down Syndrome / Delivery of Health Care, Integrated / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Adult / Female / Humans / Male Language: English Journal: J Infect Dis Year: 2022 Document Type: Article Affiliation country: Infdis